On December 28, 2023, in the gentle breeze and warm sunshine, Hangzhou VJTBio held its grand opening ceremony at the Jindi New Road Blue Valley Industrial Park, showcasing its strategic determination to continuously expand its business scale and its significant layout in rooting in the Yangtze River Delta and radiating across China. In the future, VJTBio will undertake the landing of product pipelines, becoming a new center connecting the Beijing R&D Center and the Xianju manufacturing site. Among the many industry insiders, investment institutions, and leaders of the science and technology park who gathered at the opening ceremony were Vice Director Lou Taoyuan of the Jiangnan Science and Technology City Management Bureau, Dr. Fu Xiaojun, Deputy Director of the Xianghu Laboratory, General Manager Lu Yanming of the Jindi New Road Blue Valley Life Science Park, Co-founder and COO Zhang Wenhuan of Hangzhou Liwenso Biotechnology, Vice General Manager Kong Yekai of Hangzhou Jiachi Biotechnology, Dr. Luo Haoshu, Chairman of VJTBio, General Manager Xiong Jiansheng, Vice President Han Guo, Chairman's Assistant and Executive Director Zhou Xiaoli, Sales Director Huang Zheng, Vice General Manager Hu Ling of Hangzhou VJTBio, and Production Director Li Jianxu of Zhejiang VJTBio, among others. They witnessed together the opening of a new chapter in the development of VJTBio!

At the ceremony, Vice Director Lou Taoyuan of the Jiangnan Science and Technology City Management Bureau delivered the opening speech. He warmly congratulated the establishment of Hangzhou VJTBio. As a companion of VJTBio, he has witnessed its growth and transformation. Every breakthrough embodies the unity, cooperation, and perseverance of the company. Every progress is inseparable from the care, guidance, and strong support of leaders at all levels and investment institutions in the industry. In the future, he will continue to support VJTBio, not only because he has long been optimistic about the Chinese animal durg industry and the cutting-edge biotechnology field for animal use, but also because he recognizes the professionalism of VJTBio's research and development technology and the innovative power of its technological advantages.

Dr. Luo Haoshu, Chairman of VJTBio, expressed his gratitude to Director Lou Taoyuan in his speech. Reflecting on the past, he emphasized that it was the support of industry leaders like Director Lou and colleagues in the field that allowed VJTBio to persevere through numerous challenges. Dr. Luo then elaborated on the company's development history, scientific achievements, and product advancements. He affirmed that VJTBio remains dedicated to addressing critical issues in national agricultural science and technology using biotechnology, ensuring agricultural safety and human health, and continuously pushing the boundaries in cutting-edge scientific fields.

Following Dr. Luo's speech, Lu Yanming, General Manager of Jindi New Road Blue Valley Life Science Park, delivered a congratulatory address. Representing Jindi Holdings and New Road Blue Valley, he warmly congratulated the establishment of Hangzhou VJTBio. Recognizing the rapid growth in the domestic animal health sector, New Road Blue Valley has identified the professional and innovative VJTBio team led by Dr. Luo and is committed to supporting its market expansion. Jindi New Road Blue Valley aims to continue growing alongside VJTBio and other scientists and entrepreneurs.

General Manager of VJTBio Xiong Jiansheng  and Vice President Han Guo of VJTBio also delivered speeches of gratitude. They highlighted the future of Hangzhou VJTBio, which will closely integrate with the Xianju manufacturing site, establish strong roots in Hangzhou, deepen comapny’s presence in the Yangtze River Delta, and continually expanding the its influence. The ceremony concluded with a ribbon-cutting and cake-cutting ceremony attended by goverment officals, industry colleagues, investment institutions, and VJTBio management team.

This historic moment signals that VJTBio is poised to embark on a new journey, striving for continuous progress. The company plans to leverage the latest biotechnologies to develop high-quality, low-cost, safe, and green animal protein therapeutics. With Hangzhou VJTBio as its Eastern China headquarters based in Jiangnan Science and Technology City, the company will inject new vitality into the biopharmaceutical industry in Xiaoshan, Hangzhou, and Zhejiang, promoting high-quality industry development and marking a significant new phase and chapter in VJTBio's growth